Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 121Neoplasms, Plasma Cell 36Neoplasms 14Carcinoma, Hepatocellular 13Recurrence 12Brain Neoplasms 12Prostatic Neoplasms 11Melanoma 11Central Nervous System Neoplasms 11Glioblastoma 10Leukemia 9Carcinoma, Non-Small-Cell Lung 9Leukemia, Lymphocytic, Chronic, B-Cell 8Gliosarcoma 8Waldenstrom Macroglobulinemia 7Sarcoma 7Lung Neoplasms 7Glioma 7Colorectal Neoplasms 7Carcinoma, Renal Cell 7Liver Neoplasms 6Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Kidney Neoplasms 5Immunoglobulin Light-chain Amyloidosis 5Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Follicular 4

Interventions

temsirolimus 1rofecoxib 1rindopepimut 1ovex 1imetelstat 1entinostat 1cixutumumab 1azurin (50-77) 1Thalidomide 1Re-Irradiation 1Quality of Life 1Piperazine 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Mebendazole 1Irinotecan 1Immunotherapy 1GRN163L peptide 1Everolimus 1Drug Therapy 1Dasatinib 1Cisplatin 1Carboplatin 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Stem Neoplasms × Thalidomide × Clear all
NCT00179881 2019-02-05

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2 Completed
47 enrolled

Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡